In the colitis mice model, curcumin alleviated experimental colitis by decreasing the percentage of M1 macrophages and increasing the percentage of M2 macrophages via inhibition of the TLRs/NF-κB-MAPK signaling pathway (Kang et al., 2021a). The gene discussed is NFKB1; the disease is colitis.